Patient enrollment began in July 2021. It is estimated that this trial will take 18–24 months to enrol 180 patients. The estimated study completion date is August 2022.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.